Growth Metrics

Globus Medical (GMED) EPS (Weighted Average and Diluted) (2016 - 2025)

Globus Medical's EPS (Weighted Average and Diluted) history spans 15 years, with the latest figure at $1.02 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 436.84% year-over-year to $1.02; the TTM value through Dec 2025 reached $3.93, up 424.0%, while the annual FY2025 figure was $3.92, 422.67% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $1.02 in Q4 2025 per GMED's latest filing, up from $0.88 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.49 in Q2 2025 to a low of -$0.05 in Q1 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.46, with a median of $0.44 recorded in 2021.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 3700.0% in 2024 against a maximum downside of 110.42% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.14 in 2021, then soared by 250.0% to $0.49 in 2022, then crashed by 81.63% to $0.09 in 2023, then skyrocketed by 111.11% to $0.19 in 2024, then surged by 436.84% to $1.02 in 2025.
  • Per Business Quant, the three most recent readings for GMED's EPS (Weighted Average and Diluted) are $1.02 (Q4 2025), $0.88 (Q3 2025), and $1.49 (Q2 2025).